The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote

Ine Jorgensen1, Maria M Bednar, Vishar Amin

  • 1Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.

Cell Host & Microbe
|July 20, 2011
PubMed

Insights

Chlamydia trachomatis protease (CPAF) degrades early bacterial effectors, preventing reinfection and maintaining the pathogen's niche. Inhibiting CPAF disrupts inclusion integrity and causes cell death, highlighting CPAF as a therapeutic target.

Area of Science:

  • Microbiology
  • Cell Biology
  • Protease Function

Background:

  • Chlamydia trachomatis is an obligate intracellular bacterium that manipulates host cells using effector proteins.
  • The secreted serine protease, chlamydial protease-like activity factor (CPAF), has known targets, but its precise role is unclear.
  • Lack of specific CPAF inhibitors and diverse host targets have limited understanding of CPAF's significance.

Purpose of the Study:

  • To investigate the role of CPAF in targeting early bacterial effectors.
  • To determine the function of CPAF in preventing superinfection and maintaining inclusion integrity.
  • To evaluate CPAF as a potential therapeutic target for Chlamydia infections.

Main Methods:

  • Design and utilization of a cell-permeable, CPAF-specific inhibitory peptide.
  • Analysis of CPAF's effect on early Chlamydia effectors translocated into host cells.
  • Assessment of inclusion integrity and host cell viability upon CPAF inhibition.

Main Results:

  • CPAF was found to target and degrade early Chlamydia effectors during inclusion establishment.
  • CPAF inhibition prevented superinfection by blocking the degradation of these early effectors.
  • Prolonged CPAF inhibition led to loss of inclusion integrity and caspase-1-dependent host cell death.

Conclusions:

  • CPAF plays a critical role in protecting the Chlamydia niche and ensuring pathogen survival.
  • CPAF's functions include maintaining inclusion integrity and preventing superinfection.
  • Developing specific CPAF protease inhibitors presents a promising antichlamydial therapeutic strategy.

Related Concept Videos

Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.